Metric Finance
LearnFAQ
LearnFAQ

Learn / CV

NASDAQ: CV

CapsoVision (CV) stock, explained like you're 5

CapsoVision trades on the Nasdaq under the ticker CV. It is a small cap company in the electromedical & electrotherapeutic apparatus industry, part of the healthcare sector, with a market value of about 351 million dollars.

Ticker
CV
Exchange
Nasdaq
Sector
Healthcare
Industry
Electromedical & Electrotherapeutic Apparatus
Size
Small cap, about 351 million dollars

Is CapsoVision a small, medium or large cap company?

No. CapsoVision is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 351 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How CapsoVision makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves CV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Fomento Económico Mexicano, S.A.B. de C.V. (FMX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Grupo Aeroportuario del Sureste, S.A. de C.V. (NYSE:ASR) Stock Has Consensus Price Target of $324.50 (MarketBeat)
  • A live online webcast will carry CapsoVision's Oct. 21 presentation. (Stock Titan)
  • Grupo México, S.A.B. de C.V. (GMEXICOB.MX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • CapsoVision (NasdaqCM:CV) Stock Forecast & Analyst Predictions (Simply Wall Street)

Follow CV in your daily brief

Each trading day at 5 PM ET we post what happened to CapsoVision and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow CV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about CapsoVision stock

What does CapsoVision do?

CapsoVision trades on the Nasdaq under the ticker CV. It is a small cap company in the electromedical & electrotherapeutic apparatus industry, part of the healthcare sector, with a market value of about 351 million dollars.

What is the ticker symbol for CapsoVision?

CapsoVision trades under the ticker CV on the Nasdaq.

What is CapsoVision's market cap?

CapsoVision is a small cap stock with a market cap of about 351 million dollars.

How does CapsoVision make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves CV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow CV stock every day?

Add CV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow CV daily

A free brief on CapsoVision and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ITGR · Integer Holdings
  • LIVN · LivaNova PLC
  • TMDX · TransMedics Group
  • AXGN · Axogen

Similar stocks

  • ITGRInteger Holdings
  • LIVNLivaNova PLC
  • TMDXTransMedics Group
  • AXGNAxogen

Compare CV: CV vs ITGR, CV vs LIVN, CV vs TMDX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed